The National Limb Girdle Muscular Dystrophy Conference will be held in Chicago, Illinois on August 30 – September 2, 2019 at the Hyatt Regency. The conference is dedicated to bringing every patient into an active role seeking to find cures
LGMD2A Patients Sought for Natural History Study at Nationwide Children’s Hospital
A natural history study of limb girdle muscular dystrophy type 2A (LGMD2A, a form of calpainopathy) has been initiated by Linda Lowes, PT, PhD at Nationwide Children’s Hospital in Columbus, Ohio. The aim of this study is to observe
Myonexus Therapeutics announces initiation of a gene therapy clinical trial for LGMD2E
On November 8, 2018, Myonexus Therapeutics announced the initiation of a clinical trial evaluating MYO-101, a novel gene therapy candidate for beta-sarcoglycanopathy, also known as limb girdle muscular dystrophy type 2E (LGMD2E). The trial is underway at Nationwide Children’s Hospital’s